331 – 340 of 830
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.
(
- Contribution to journal › Letter
-
Mark
Glucose-Dependent Insulinotropic Polypeptide (GIP) Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB.
(
- Contribution to journal › Article
-
Mark
Implementation of World Health Organization Package of Essential Noncommunicable Disease Interventions (WHO PEN) for Primary Health Care in Low-Resource Settings: A Policy Statement From the World Hypertension League.
(
- Contribution to journal › Article
-
Mark
Follow-up duration influences the relative importance of OGTT and optimal timing of glucose measurements for predicting future type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Copeptin predicts coronary artery disease cardiovascular and total mortality.
(
- Contribution to journal › Article
-
Mark
Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus.
(
- Contribution to journal › Article
-
Mark
Restructuring Hypertension Congresses and Scientific Meetings for Improved Hypertension Prevention and Control.
(
- Contribution to journal › Article
-
Mark
The genetic architecture of type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Fetma är inte självklart skadlig hos alla individer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes : A meta-analysis
(
- Contribution to journal › Article